Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium; Botulinum”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT00314080
What this trial is testing

Treatment of Survivors After Botulism Outbreak

Who this might be right for
Respiratory FailureBotulism
Department of Medical Services Ministry of Public Health of Thailand 18
Not applicableStudy completedNCT03658902
What this trial is testing

Retrospective Epidemiological Study on Botulism in Intensive Care Units in France

Who this might be right for
Botulism; Poisoning
Centre Hospitalier le Mans 52
Early research (Phase 1)Study completedNCT03603665
What this trial is testing

Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults

Who this might be right for
Botulism
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT01421719
What this trial is testing

Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Who this might be right for
Parkinson's DiseaseNeurogenic BladderUrinary Incontinence+1 more
Stanford University 20
Not applicableStudy completedNCT02055183
What this trial is testing

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Who this might be right for
Botulism
Emergent BioSolutions 162
Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Testing effectiveness (Phase 2)Study completedNCT03676634
What this trial is testing

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

Who this might be right for
Botulism
California Department of Public Health 32
Large-scale testing (Phase 3)Study completedNCT05531968
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

Who this might be right for
Glabellar Lines
BMI Korea 278
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06580236
What this trial is testing

Study of the Drug B11-FC (Botulism Treatment)

Who this might be right for
Botulism
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 40
Early research (Phase 1)Study completedNCT02779140
What this trial is testing

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

Who this might be right for
Botulism
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableUnknownNCT04550793
What this trial is testing

Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients

Who this might be right for
StrokeSpasticity, MuscleBotulism+2 more
National Taiwan University Hospital 100
Not applicableStudy completedNCT04604379
What this trial is testing

Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity

Who this might be right for
Upper and/or Lower Limb Focal Spasticity
Ipsen 123
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Early research (Phase 1)Study completedNCT00636519
What this trial is testing

Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle

Who this might be right for
Healthy Volunteers
Emergent BioSolutions 36
Testing effectiveness (Phase 2)Study completedNCT00934687
What this trial is testing

Botulinum Toxin for the Treatment of Depression

Who this might be right for
Depression
University Hospital, Basel, Switzerland 30
Not applicableStudy completedNCT00004401
What this trial is testing

Study of Human Botulism Immunoglobulin in Infants With Botulism

Who this might be right for
Infant BotulismBotulism
California Department of Health Services 120
Not applicableStudy completedNCT04179682
What this trial is testing

A Pilot Study of Constraint Induced Movement Therapy in Preschool Cerebral Palsy After Botulism Toxin Injection

Who this might be right for
Cerebral Palsy, SpasticRehabilitation
Changhua Christian Hospital 6
Testing effectiveness (Phase 2)Study completedNCT04281095
What this trial is testing

A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01701999
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

Who this might be right for
Botulism
California Department of Public Health 45
Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381
Load More Results